ISSN: 2040-1116

Journal Home

Journal of Diabetes Investigation Q1 Unclaimed

Blackwell Publishing Asia Pty Ltd Australia

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Diabetes Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Endocrinology, Diabetes and Metabolism with an H index of 68. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on endocrinology, life style, diabetes. It has an SJR impact factor of 0,997 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,997.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Internal Medicine (Q1) Medicine (miscellaneous) (Q1) Endocrinology, Diabetes and Metabolism (Q2)

Price

2700 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,997

SJR Impact factor

68

H Index

178

Total Docs (Last Year)

761

Total Docs (3 years)

5856

Total Refs

2300

Total Cites (3 years)

647

Citable Docs (3 years)

3.04

Cites/Doc (2 years)

32.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Endocrinology Life style Diabetes

Best articles by citations

Increasing achievement of the target goals for glycemic, blood pressure and lipid control for adults with diagnosed diabetes in Korea

Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks

Severe hypoglycemia predicts major adverse outcomes in diabetic patients undergoing glycemic control regimes

Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy

Glycated hemoglobin variability: A potential new risk marker for diabetes complications?

Novel murine model of congenital diabetes: The insulin hyposecretion mouse

Diabetes and pancreas size, does it matter?

Combined intervention for the tertiary prevention of type 1 diabetes

Impact of baseline characteristics on glycemic effects of add-on saxagliptin or acarbose to metformin therapy: subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus

Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3)

Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus

SHOW MORE ARTICLES

Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes

Effects of medical therapies on retinopathy progression in type 2 diabetes: Is blood pressure control the lower the better?

Case of anal fistula with Fournier's gangrene in an obese type 2 diabetes mellitus patient

Stabilization of postprandial blood glucose fluctuations by addition of glucagon like polypeptide-analog administration to intensive insulin therapy

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines

Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes

From sugar to kidney: A never-ending battle

Predictor variables and an equation for estimating HbA1c attainable by initiation of basal supported oral therapy†

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial

Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta-analysis of randomized control trials

Optimal cut-off levels of obesity indices by different definitions of metabolic syndrome in a southeast rural Chinese population

Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects